5.7 C
Johannesburg
Sunday, August 9, 2020
- Advertisement -

World’s First COVID-19 Vaccine? A Ray of Hope as Russia’s Sechenov University Successfully Completes Human Trials

MOSCOW| As the world races to come up with an effective vaccine against Covid-19, Russia has become the first country to successfully complete clinical trials of COVID-19 vaccine on humans.

According to reports, the clinical trials of the world’s first coronavirus vaccine on volunteers at Sechenov First Moscow State Medical University has been successfully completed.

The director of the Institute for Translational Medicine and Biotechnology Vadim Tarasov confirmed the development to Sputnik news, adding that the first group of volunteers would be discharged on Wednesday and the second on July 20.

“Sechenov University has successfully completed tests on volunteers of the world’s first vaccine against coronavirus,” Tarasov said.

According to TASS, Russia’s largest news agency, the first stage of research on the vaccine started on June 18 when a group of 18 volunteers were vaccinated, and the second stage on June 23 with a group of 20 volunteers being vaccinated. The volunteers will remain under medical supervision on an out-patient basis after being discharged.

Alexander Lukashev, the director of the Institute of Medical Parasitology, Tropical and Vector-Borne Diseases at Sechenov University, said that the objective of this stage of the study was to show the vaccine’s safety for human health, which was successfully done.

“The safety of the vaccine is confirmed. It corresponds to the safety of those vaccines that are currently on the market,” Lukashev told Sputnik.

The further vaccine development plan is already being determined by the developer’s strategy, including the complexity of the epidemiological situation with the virus and the possibility of scaling up production, Lukashev added.

“Sechenov University in a pandemic situation acted not only as an educational institution but also as a scientific and technological research centre that is able to participate in the creation of such important and complex products as drugs … We worked with this vaccine, starting with preclinical studies and protocol development, and clinical trials are currently underway,” Tarasov noted.

However, there was no further information on when this vaccine would enter the commercial production stage.

(Source: Agency inputs)

- Advertisement -
- Advertisement -

Related articles

LEAVE A REPLY

Please enter your comment!
Please enter your name here

- Advertisement -

Latest articles

SPECIAL REPORT| How Africa May Lose Out On The Race To Solve The COVID Conundrum

WANJOHI KABUKURU TWO French medical Professors Camille Locht of the French National Institute of Health and Medical Research (INSERM)...

Three South African Vice-Chancellors Paint A Post-COVID Picture For Universities

WHAT long-lasting changes to South Africa’s higher education sector has the pandemic brought? And how will these affect the way universities deliver...

Motshekga: Parts Of The 2020 School Curriculum Will Be Pushed To 2021

NYAKALLO TEFU BASIC Education Minister Angie Motshekga says some of the school work for some grades will be carried...

We’re Facing A ‘Generational Catastrophe’ In Education, UN Secretary-General Antonio Guterres Warned On Tuesday

THE world is facing a "generational catastrophe" because of school closures during the coronavirus pandemic, UN Secretary-General Antonio Guterres warned Tuesday.

COSAS Threatens To Render Private Schools ‘Ungovernable’

SANDILE MOTHA THE Congress of South African Students has vowed to make private schools ungovernable should they remain open...